CellumedLtd Balance Sheet Health
Financial Health criteria checks 6/6
CellumedLtd has a total shareholder equity of ₩31.4B and total debt of ₩11.0B, which brings its debt-to-equity ratio to 35%. Its total assets and total liabilities are ₩75.0B and ₩43.6B respectively.
Key information
35.0%
Debt to equity ratio
₩10.98b
Debt
Interest coverage ratio | n/a |
Cash | ₩12.42b |
Equity | ₩31.38b |
Total liabilities | ₩43.60b |
Total assets | ₩74.98b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A049180's short term assets (₩58.7B) exceed its short term liabilities (₩39.6B).
Long Term Liabilities: A049180's short term assets (₩58.7B) exceed its long term liabilities (₩4.0B).
Debt to Equity History and Analysis
Debt Level: A049180 has more cash than its total debt.
Reducing Debt: A049180's debt to equity ratio has reduced from 54.8% to 35% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A049180 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A049180 has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 15.4% each year.